Publikationen in Zusammenarbeit mit Forschern von Università de Roma La Sapienza (25)

2024

  1. Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Mesoangioblasts at 20: From the embryonic aorta to the patient bed

    Frontiers in Genetics, Vol. 13

2021

  1. AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity

    Nature, Vol. 592, Núm. 7856, pp. 799-803

  2. Autophagy and the lysosomal system in cancer

    Cells, Vol. 10, Núm. 10

  3. Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology

    Frontiers in Pharmacology

  4. Editorial: Novel Cancer Treatments Based on Autophagy Modulation

    Frontiers in Pharmacology

  5. Editorial: Trained Immunity-Based Vaccines

    Frontiers in Immunology

  6. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  7. Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions

    Frontiers in Immunology, Vol. 12

  8. Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies

    Cellular and Molecular Life Sciences, Vol. 78, Núm. 5, pp. 1853-1860

2020

  1. Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment

    Frontiers in Pharmacology, Vol. 11

2019

  1. Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches

    Oxidative medicine and cellular longevity

  2. Sestrins as a therapeutic bridge between ros and autophagy in cancer

    Cancers, Vol. 11, Núm. 10

  3. Sestrins at the interface of ROS control and autophagy regulation in health and disease

    Oxidative Medicine and Cellular Longevity, Vol. 2019

2017

  1. Emerging insight into MAPK inhibitors and immunotherapy in colorectal cancer

    Current Medicinal Chemistry, Vol. 24, Núm. 14, pp. 1383-1402

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2009

  1. Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency

    Cardiovascular Research, Vol. 83, Núm. 4, pp. 707-716